Aglaris Cell SL

Aglaris Cell SL

General
Jobs 0
Shortlists/Awards 1
Pricing strategy 0
Partners/Competitors 11
Last update: Dec 6, 2024 Last update: Dec 6, 2024
General
Jobs
Shortlists/Awards
Pricing strategy
Partners/Competitors

Details

Legal residence:Spain
Organization type:Supplier / manufacturer
Funding agencies:Other, Horizon 2020
Other, Horizon 2020 (2014 - 2020)
Sectors:Health
Health
Sanctions:Check now
Status:
Active

Attachments 0

About

The Aglaris Facer 1.0 bioreactor is the first fully-automated cell culture bioreactor which doesn’t use trypsin. This enables users to obtain large amounts of cells with simple and easy-to-use equipment.Automating cell culture with various control and traceability features makes the Aglaris Facer 1.0 ideal for “manufacturing” cells. Its automated processes reduce the need for human intervention and monitoring. In addition, its fully-enclosed system minimizes contamination risks from cell handling.

At Aglaris we envision a world in which personalised medicine, regenerative medicine and cell therapies are the tools that propel the field of general medicine towards achieving new goals like finding the cure for illnesses which, to date, have been incurable.

Our mission is to change the current cell culture process by completely automating all cell culture steps

Awards

Top partners

Top competitors

Want to unlock full information?
Register with us or sign in to access the organization database.
Similar Companies
By Sectors and Organization Types